Full Episode
Saturday, Sep 13
PBS NewsHour
  • Episodes
  • Podcasts
  • Newsletters
  • The Latest
  • Politics
    Politics
    • Brooks and Capehart
    • Politics Monday
    • Supreme Court
  • Arts
    Arts
    • CANVAS
    • Poetry
    • Now Read This
  • Nation
    Nation
    • Supreme Court
    • Race Matters
    • Essays
    • Brief But Spectacular
  • World
    World
    • Agents for Change
  • Economy
    Economy
    • Making Sen$e
    • Paul Solman
  • Science
    Science
    • The Leading Edge
    • ScienceScope
    • Basic Research
    • Innovation and Invention
  • Health
    Health
    • Long-Term Care
  • Education
    Education
    • Teachers' Lounge
    • Student Reporting Labs
  • For Teachers
    Education
    • Newshour Classroom
  • About
    • Feedback
    • Funders
    • Support
    • Jobs

Clarity when it matters most

With federal funding gone, your monthly support powers PBS News
Donate now
PBS News

Get news alerts from PBS News

Turn on desktop notifications?

johnson & johnson

  • Full Episodes
  • Podcasts
  • Newsletters
  • Live

Sep 08

What to know about booster shots if you received Johnson & Johnson’s COVID-19 vaccine

By Maureen Ferran, The Conversation

It's been six months since the Johnson & Johnson vaccine received emergency use authorization. What does the data show about its efficacy, side effects and protection from variants?…

Continue reading

Jul 21

Watch 7:33
How the opioids settlement will impact communities affected by addiction

After more than two years of negotiations, a number of states agreed to a $26 billion settlement with three large drug distributors and Johnson & Johnson for their roles in the opioids epidemic. Half a million deaths over two decades…

Continue watching

Jul 15

Johnson & Johnson recalling sunscreens due to benzene traces

By Linda A. Johnson, Associated Press

J&J said it's unlikely users would be harmed. The recall includes all can sizes and all levels of SPF, or sun protection factor. Consumers can contact the company for a refund.

Continue reading

Jul 13

FDA adds warning about rare reaction to J&J COVID-19 vaccine

By Matthew Perrone, Mike Stobbe, Associated Press

U.S. regulators on Monday added a new warning to Johnson & Johnson’s COVID-19 vaccine about links to a rare and potentially dangerous neurological reaction, but said it’s not entirely clear the shot caused the problem.

Continue reading

Jun 26

J&J agrees to pay $230M to settle New York opioid claim

By Associated Press

The deal announced on Saturday requires Johnson & Johnson to make a series of payments over nine years that will cover the total. The drugmaker also agreed to end the manufacturing and distribution of opioids across New York and the…

Continue reading

Jun 21

A mix-and-match approach to COVID-19 vaccines could provide logistical and immunological benefits

By Maureen Ferran, The Conversation

Various companies use different ingredients and different delivery systems in their COVID-19 vaccines. Researchers are investigating whether it's better for individuals to mix what's available.

Continue reading

Jun 11

Watch 4:37
News Wrap: FDA orders disposal of 60 million Johnson & Johnson doses from troubled factory

In our news wrap Friday, the FDA will allow 10 million doses of the Johnson & Johnson vaccine from a troubled Baltimore factory to be used, but about 60 million doses will be thrown out. Also, the U.N. warned violence…

Continue watching

Jun 11

Johnson & Johnson vaccine doses to be released, but many will be tossed

By Zeke Miller, Linda A. Johnson, Associated Press

The Food and Drug Administration announced that it had determined that two batches from the plant could be released. But it said several other batches are not suitable for use and additional batches are still under review.

Continue reading

Jun 10

U.S. officials extend expiration dates on Johnson & Johnson vaccine doses

By Matthew Perrone, Associated Press

The company said a FDA review concluded the shots remain safe and effective up to 4-1/2 months.

Continue reading

Jun 01

Justices reject Johnson & Johnson appeal of $2 billion talc verdict

By Associated Press

The Supreme Court is leaving in place a $2 billion verdict in favor of women who claim they developed ovarian cancer from using Johnson & Johnson talc products.

Continue reading

Jump to the First Page Previous Page
1 2 3 4 5 6 7
Next Page Jump to the Last Page

Support Provided By: Learn more

web ad

Educate your inbox

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Form error message goes here.

Thank you. Please check your inbox to confirm.

Full Episode
Saturday, Sep 13
  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You
  • Friends of the News Hour
PBS News

© 1996 - 2025 NewsHour Productions LLC. All Rights Reserved.

PBS is a 501(c)(3) not-for-profit organization.

Sections

  • The Latest
  • Politics
  • Arts
  • Nation
  • World
  • Economy
  • Science
  • Health
  • Education

About

  • About Us
  • TV Schedule
  • Press
  • Feedback
  • Funders
  • Support
  • Newsletters
  • Podcasts
  • Jobs
  • Privacy
  • Terms of Use

Stay Connected

  • Facebook
  • YouTube
  • Instagram
  • X
  • TikTok
  • Threads
  • RSS

Subscribe to Here's the Deal with Lisa Desjardins

Form error message goes here.

Thank you. Please check your inbox to confirm.

Support our journalism

Support for News Hour Provided By

  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You